









市場行情
/
股票
/
nasdaq-idxx
/

IDEXX Laboratories Inc

IDXX

700.550USD

-3.650-0.52%

收盤 12/15, 16:00（美東）報價延遲15分鐘

56.04B總市值

55.13本益比TTM



IDEXX Laboratories Inc

700.550

-3.650-0.52%

概覽公司財務分析

概覽

公司

財務

分析

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc簡介



公司代碼IDXX

公司名稱IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOEmerson (Andrew)

員工數量11000

證券類型Ordinary Share

年結日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編04092-2041

電話12075560300

網址https://www.idexx.com/

公司代碼IDXX

上市日期Jun 21, 1991

CEOEmerson (Andrew)

IDEXX Laboratories Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

地區USD

名稱

營收

佔比

United States

717.87M

64.70%

Europe & Middle East & Africa (EMEA) (Region)

233.27M

21.03%

Asia Pacific

89.30M

8.05%

Canada

46.69M

4.21%

Latin America

22.33M

2.01%

業務

地區

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

878.00M

79.14%

IDEXX VetLab consumables

375.11M

33.81%

Reference laboratory diagnostic and consulting services

367.69M

33.14%

Rapid assay products

100.24M

9.04%

CAG Diagnostics capital - instruments

85.85M

7.74%

其他

-697.43M

-62.86%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

其他

70.21%

持股股東

佔比

The Vanguard Group, Inc.

12.43%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

其他

70.21%

股東類型

持股股東

佔比

Investment Advisor

53.77%

Investment Advisor/Hedge Fund

30.95%

Research Firm

3.98%

Pension Fund

2.91%

Bank and Trust

1.86%

Individual Investor

0.69%

Sovereign Wealth Fund

0.59%

Hedge Fund

0.54%

Family Office

0.50%

其他

4.22%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

2319

77.76M

97.19%

-4.03M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

9.84M

12.3%

+19.20K

+0.20%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.30M

6.63%

-132.86K

-2.44%

Jun 30, 2025

State Street Investment Management (US)

3.55M

4.44%

-95.45K

-2.62%

Jun 30, 2025

Fundsmith LLP

2.64M

3.3%

-9.04K

-0.34%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.46M

3.08%

+54.40K

+2.26%

Jun 30, 2025

Baron Capital Management, Inc.

2.03M

2.54%

-27.16K

-1.32%

Jun 30, 2025

Invesco Capital Management (QQQ Trust)

1.65M

2.06%

-5.80K

-0.35%

Aug 31, 2025

Principal Global Investors (Equity)

1.13M

1.41%

+1.75K

+0.16%

Jun 30, 2025

Polen Capital Management, LLC

1.20M

1.49%

+1.12M

+1519.07%

Jun 30, 2025

Walter Scott & Partners Ltd.

756.69K

0.95%

+597.11K

+374.18%

Jun 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

ProShares Pet Care ETF

9.4%

iShares U.S. Medical Devices ETF

4.42%

First Trust Water ETF

3.98%

SMI 3Fourteen Full-Cycle Trend ETF

3.9%

Nuveen ESG Mid-Cap Growth ETF

3.47%

Adaptive Core ETF

2.61%

First Trust S&P 500 Economic Moat Index ETF

2.25%

Acruence Active Hedge US Equity ETF

2.18%

Tema Durable Quality ETF

2.1%

Putnam Sustainable Future ETF

2.03%

ProShares Pet Care ETF

佔比9.4%

iShares U.S. Medical Devices ETF

佔比4.42%

First Trust Water ETF

佔比3.98%

SMI 3Fourteen Full-Cycle Trend ETF

佔比3.9%

Nuveen ESG Mid-Cap Growth ETF

佔比3.47%

Adaptive Core ETF

佔比2.61%

First Trust S&P 500 Economic Moat Index ETF

佔比2.25%

Acruence Active Hedge US Equity ETF

佔比2.18%

Tema Durable Quality ETF

佔比2.1%

Putnam Sustainable Future ETF

佔比2.03%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

IDEXX Laboratories Inc的前五大股東是誰？



IDEXX Laboratories Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：9.84M
佔總股份比例：12.30%。
BlackRock Institutional Trust Company, N.A.
持有股份：5.30M
佔總股份比例：6.63%。
State Street Investment Management (US)
持有股份：3.55M
佔總股份比例：4.44%。
Fundsmith LLP
持有股份：2.64M
佔總股份比例：3.30%。
Geode Capital Management, L.L.C.
持有股份：2.46M
佔總股份比例：3.08%。